Mapping of the norepinephrine transporter in the human brain using PET with (S,S)-[18F]FMeNER-D2

NeuroImage

Volumn 42, Issue 2, 2008, Pages 474-482

  Takano, Akihiro ^a   Varrone, Andrea ^a   Gulyás, Balázs ^a   Karlsson, Per ^a   Tauscher, Johannes ^b   Halldin, Christer ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; NORADRENALIN TRANSPORTER; RADIOLIGAND;

ADULT; ARTICLE; BRAIN AQUEDUCT; BRAIN MAPPING; BRAIN STEM; CALCULATION; CLINICAL ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; LOCUS CERULEUS; MALE; MESENCEPHALON; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PULVINAR; RECEPTOR BINDING; THALAMUS; VALIDITY;

ADULT; BRAIN; HUMANS; MALE; MORPHOLINES; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TISSUE DISTRIBUTION;

EID: 47949088767     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2008.05.040     Document Type: Article

References (34)

1. Arango V., Underwood M.D., and Mann J.J. Fewer pigmented neurons in the locus coeruleus of uncomplicated alcoholics. Brain Res. 650 (1994) 1-8
2. Belej T., Manji D., Sioutis S., Barros H.M., and Nobrega J.N. Changes in serotonin and norepinephrine uptake sites after chronic cocaine: pre- vs. post-withdrawal effects. Brain Res. 736 (1996) 287-296
3. 3H]desmethylimipramine binding sites in rat brain by quantitative autoradiography. J. Neurosci. 3 (1983) 1069-1076
4. Buchsbaum M.S., Someya T., Teng C.Y., Abel L., Chin S., Najafi A., Haier R.J., Wu J., and Bunney Jr. W.E. PET and MRI of the thalamus in never-medicated patients with schizophrenia. Am. J. Psychiatry 153 (1996) 191-199
5. 11C]DASB and positron emission tomography. Biol. Psychiatry 60 (2006) 207-217
6. Chikama M., McFarland N.R., Amaral D.G., and Haber S.N. Insular cortical projections to functional regions of the striatum correlate with cortical cytoarchitectonic organization in the primate. J. Neurosci. 17 (1997) 9686-9705
7. 2-dopamine receptors studied by PET-a comparison to the equilibrium analysis. J. Cereb. Blood Flow. Metab. 9 (1989) 696-708
8. Foote S.L., Bloom F.E., and Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 63 (1983) 844-914
9. Heneka M.T., Ramanathan M., Jacobs A.H., Dumitrescu-Ozimek L., Bilkei-Gorzo A., Debeir T., Sastre M., Galldiks N., Zimmer A., Hoehn M., Heiss W.D., Klockgether T., and Staufenbiel M. Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice. J. Neurosci. 26 (2006) 1343-1354
10. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., and Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 27 (2007) 1533-1539
11. 3H]mazindol autoradiography. J. Neurosci. 5 (1985) 1513-1521
12. 11C]raclopride. Synapse 59 (2006) 427-434
13. 11C]O-methyl reboxetine and PET: problems and progress. Nucl. Med. Biol. 34 (2007) 667-679
14. 1A receptors and 5-HTT in the human brain. Psychopharmacology (Berl.) 195 (2007) 425-433
15. Marner L., Søborg C., and Pakkenberg B. Increased volume of the pigmented neurons in the locus coeruleus of schizophrenic subjects: a stereological study. J. Psychiatr. Res. 39 (2005) 337-345
16. Mash D.C., Ouyang Q., Qin Y., and Pablo J. Norepinephrine transporter immunoblotting and radioligand binding in cocaine abusers. J. Neurosci. Methods 143 (2005) 79-85
17. Mesulam M.M., and Mufson E.J. Insula of the old world monkey. I. Architectonics in the insulo-orbito-temporal component of the paralimbic brain. J. Comp. Neurol. 212 (1982) 1-22
18. Oke A.F., Carver L.A., Gouvion C.M., and Adams R.N. Three-dimensional mapping of norepinephrine and serotonin in human thalamus. Brain Res. 763 (1997) 69-78
19. Ordway G.A., Stockmeier C.A., Cason G.W., and Klimek V. Pharmacology and distribution of norepinephrine transporters in the human locus coeruleus and raphe nuclei. J. Neurosci. 17 (1997) 1710-1719
20. Reig S., Penedo M., Gispert J.D., Pascau J., Sánchez-González J., García-Barreno P., and Desco M. Impact of ventricular enlargement on the measurement of metabolic activity in spatially normalized PET. Neuroimage 35 (2007) 748-758
21. 11C]MeNER. Nucl. Med. Biol. 30 (2003) 707-714
22. Schou M., Halldin C., Sóvágó J., Pike V.W., Hall H., Gulyás B., Mozley P.D., Dobson D., Shchukin E., Innis R.B., and Farde L. PET evaluation of novel radiofluorinated reboxetine analogs as norepinephrine transporter probes in the monkey brain. Synapse 53 (2004) 57-67
23. 2. Eur. Neuropsychopharmacol. 15 (2005) 517-520
24. Schulz J.B., Skalej M., Wedekind D., Luft A.R., Abele M., Voigt K., Dichgans J., and Klockgether T. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy. Ann. Neurol. 45 (1999) 65-74
25. 2. Psychopharmacology (Berl.) 188 (2006) 119-127
26. Smith H.R., Beveridge T.J., and Porrino L.J. Distribution of norepinephrine transporters in the non-human primate brain. Neuroscience 138 (2006) 703-714
27. Swanson L.W., and Hartman B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol. 163 (1975) 467-505
28. Szabó C.A., Lancaster J.L., Xiong J., Cook C., and Fox P. MR imaging volumetry of subcortical structures and cerebellar hemispheres in normal persons. A.J.N.R. Am. J. Neuroradiol. 24 (2003) 644-647
29. 2 in monkey brains. Eur. J. Nucl. Med. Mol. Imaging 34 S2 (2007) S206
30. 2. Eur. J. Nucl. Med. Mol. Imaging 35 (2008) 153-157
31. 3H]nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography or by homogenate binding. J. Pharmacol. Exp. Ther. 260 (1992) 427-436
32. Tejani-Butt S.M., Yang J., and Zaffar H. Norepinephrine transporter sites are decreased in the locus coeruleus in Alzheimer's disease. Brain Res. 631 (1993) 147-150
33. Yasui Y., Breder C.D., Saper C.B., and Cechetto D.F. Autonomic responses and efferent pathways from the insular cortex in the rat. J. Comp. Neurol. 303 (1991) 355-374
34. 2 receptor binding in subregions of the thalamus in schizophrenia. Am. J. Psychiatry 161 (2004) 1016-1022